170 related articles for article (PubMed ID: 3597059)
1. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.
Casals-Stenzel J
Immunopharmacology; 1987 Apr; 13(2):117-24. PubMed ID: 3597059
[TBL] [Abstract][Full Text] [Related]
2. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
Heuer HO
Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
[TBL] [Abstract][Full Text] [Related]
3. Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge.
Heuer H; Casals-Stenzel J
Agents Actions Suppl; 1988; 23():207-15. PubMed ID: 3262991
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
Heuer HO
Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.
Heuer H; Casals-Stenzel J
Prog Clin Biol Res; 1989; 308():925-30. PubMed ID: 2675077
[No Abstract] [Full Text] [Related]
6. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice.
Sakuma Y; Muramoto K; Harada K; Katayama S; Tsunoda H; Katayama K
Prostaglandins; 1991 Dec; 42(6):541-55. PubMed ID: 1801063
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
Terasawa M; Aratani H; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.
Casals-Stenzel J
Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490
[TBL] [Abstract][Full Text] [Related]
10. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
Heuer HO
J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086
[TBL] [Abstract][Full Text] [Related]
11. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
Desquand S; Lefort J; Dumarey C; Vargaftig BB
Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel PAF antagonist, E6123, on passive anaphylaxis.
Sakuma Y; Tsunoda H; Katayama S; Harada K; Obaishi H; Shirato M; Yamada K; Miyazawa S; Okano K; Machida Y
Agents Actions Suppl; 1990; 31():255-8. PubMed ID: 2080758
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
[TBL] [Abstract][Full Text] [Related]
16. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
Lohman I; Halonen M
Am Rev Respir Dis; 1990 Aug; 142(2):390-7. PubMed ID: 2382903
[TBL] [Abstract][Full Text] [Related]
17. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
19. Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor.
Desquand S; Ruffié C; Lefort J; Hatmi M; Pina M; Priego JG; Vargaftig BB
Eur J Pharmacol; 1993 Apr; 235(1):101-8. PubMed ID: 7686102
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
